078160 메디포스트
기본 정보
- 섹터: KOSDAQ:제조
- 시가총액: 3,504억원 (2026-06-30 기준)
- 첫 등장: 2026-06-11 (누적 2일)
- 태그: 매크로/바이오헬스 · 줄기세포 · 제대혈 · 골관절염치료제 · 바이오
- 네이버 금융: 🔗
기업개요
- 동사는 2000년 제대혈보관사업 및 줄기세포치료제 개발을 목적으로 설립되어, 2005년 코스닥에 상장됨.
- 북미의 MEDIPOST, Inc., 일본의 MEDIPOST K.K., 이뮤니크와 메디포스트씨디엠오를 통해 다양한 사업을 운영하고 있음.
- 동사는 제대혈은행 ‘셀트리’로 국내 1위 점유율을 유지하며, 줄기세포치료제 ‘카티스템’과 건강기능식품 ‘모비타’를 판매하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 10,060 | 10,440 | 🔴 +3.78% | +0.40%p | ×0.8 | 🟢 외인 | +1.8억 | +1.7 | +0.0 | -0.1 | +0.1 | -1.7 | +0.0 |
| 2026-08-13 | 10,300 | 10,060 | 🔵 -2.33% | -0.10%p | ×0.6 | 🔻 개인 | -1.4억 | -1.4 | +0.0 | +0.0 | +0.0 | +1.8 | -0.3 |
| 2026-08-12 | 10,420 | 10,300 | 🔵 -1.15% | -0.38%p | ×0.8 | 🔻 개인 | -0.6억 | -0.6 | +0.0 | +0.1 | +0.0 | +0.6 | -0.0 |
| 2026-08-11 | 10,350 | 10,420 | 🔴 +0.68% | +0.20%p | ×0.6 | 🟢 외인 | +0.4억 | +0.4 | +0.0 | -0.1 | +0.0 | -0.4 | +0.0 |
| 2026-08-10 | 9,810 | 10,350 | 🔴 +5.50% | +0.51%p | ×1.4 | ⚫ 그외 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | -0.2 | +0.2 |
| 2026-08-07 | 9,860 | 9,810 | 🔵 -0.51% | -0.41%p | ×0.7 | 🟢 외인 | +0.4억 | +0.4 | +0.0 | -0.0 | +0.0 | -0.4 | +0.0 |
| 2026-08-06 | 9,740 | 9,860 | 🔴 +1.23% | -0.41%p | ×1.5 | 🟣 투신 | -0.2억 | -0.9 | +0.0 | +0.1 | +0.7 | -0.0 | +0.2 |
| 2026-08-05 | 9,940 | 9,740 | 🔵 -2.01% | +0.30%p | ×1.2 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | +0.1 | +0.0 | +0.8 | -0.0 |
| 2026-08-04 | 8,360 | 9,940 | 🔴 +18.90% | +0.96%p | ×3.1 | 🟢 외인 | +7.0억 | +4.1 | +2.9 | +0.1 | +0.0 | -7.2 | +0.1 |
| 2026-08-03 | 8,350 | 8,360 | 🔴 +0.12% | -0.36%p | ×0.8 | 🟢 외인 | +0.8억 | +0.8 | +0.0 | +0.0 | +0.0 | -1.0 | +0.2 |
| 2026-07-31 | 7,520 | 8,350 | 🔴 +11.04% | +0.14%p | ×0.9 | 🟢 외인 | +3.6억 | +3.6 | +0.0 | +0.1 | +0.0 | -3.6 | -0.0 |
| 2026-07-30 | 7,600 | 7,520 | 🔵 -1.05% | -0.92%p | ×0.7 | 🟢 외인 | +1.8억 | +1.7 | +0.0 | +0.0 | +0.0 | -2.0 | +0.2 |
| 2026-07-29 | 8,030 | 7,600 | 🔵 -5.35% | +1.00%p | ×1.6 | 🔻 개인 | -1.4억 | -1.4 | +0.0 | -0.0 | -0.0 | +1.4 | +0.0 |
| 2026-07-28 | 8,350 | 8,030 | 🔵 -3.83% | -0.48%p | ×0.8 | 🔻 개인 | -1.8억 | -1.8 | +0.0 | +0.0 | +0.0 | +1.8 | +0.0 |
| 2026-07-27 | 8,210 | 8,350 | 🔴 +1.71% | -0.60%p | ×0.9 | 🟢 외인 | +0.7억 | +0.7 | +0.0 | +0.0 | +0.0 | -0.7 | -0.0 |
| 2026-07-24 | 8,460 | 8,210 | 🔵 -2.96% | +1.53%p | ×0.6 | 🔻 개인 | -2.2억 | -1.6 | +0.0 | -0.0 | -0.6 | +2.2 | +0.0 |
| 2026-07-23 | 8,110 | 8,460 | 🔴 +4.32% | -0.98%p | ×0.6 | 🟢 외인 | +2.2억 | +2.2 | +0.0 | -0.0 | +0.0 | -2.2 | +0.0 |
| 2026-07-22 | 8,190 | 8,110 | 🔵 -0.98% | +0.97%p | ×0.8 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | -0.1 | +0.0 | +0.4 | +0.0 |
| 2026-07-21 | 8,390 | 8,190 | 🔵 -2.38% | +1.55%p | ×0.9 | 🟢 외인 | +0.6억 | +0.6 | +0.0 | -0.1 | +0.0 | -0.8 | +0.3 |
| 2026-07-20 | 8,790 | 8,390 | 🔵 -4.55% | +2.73%p | ×0.5 | 🔻 개인 | -1.7억 | -1.7 | +0.0 | -0.0 | +0.0 | +1.7 | +0.0 |
| 2026-07-16 | 8,970 | 8,790 | 🔵 -2.01% | +0.33%p | ×0.6 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | -0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-15 | 8,310 | 8,970 | 🔴 +7.94% | -1.21%p | ×0.9 | 🟢 외인 | +3.5억 | +3.5 | +0.0 | -0.0 | +0.0 | -3.7 | +0.1 |
| 2026-07-14 | 8,600 | 8,310 | 🔵 -3.37% | -0.70%p | ×0.9 | 🔻 개인 | -0.9억 | -0.9 | +0.0 | -0.1 | +0.0 | +0.8 | +0.2 |
| 2026-07-13 | 9,090 | 8,600 | 🔵 -5.39% | +1.65%p | ×0.8 | 🔻 개인 | -2.5억 | -2.5 | +0.0 | +0.0 | +0.0 | +2.5 | +0.0 |
| 2026-07-10 | 8,470 | 9,090 | 🔴 +7.32% | -1.77%p | ×0.8 | 🟢 외인 | +2.9억 | +2.9 | +0.0 | +0.0 | +0.0 | -2.8 | -0.1 |
| 2026-07-09 | 8,420 | 8,470 | 🔴 +0.59% | -0.12%p | ×0.9 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | -0.1 | +0.0 | +0.2 | +0.1 |
| 2026-07-08 | 9,160 | 8,420 | 🔵 -8.08% | -2.62%p | ×2.9 | 🔻 개인 | -19.3억 | -17.5 | -1.8 | -0.1 | +0.0 | +20.0 | -0.6 |
| 2026-07-07 | 9,160 | 9,160 | ⚪ +0.00% | +1.64%p | ×0.6 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | -0.2 | +0.0 | +1.0 | -0.0 |
| 2026-07-06 | 9,040 | 9,160 | 🔴 +1.33% | +0.00%p | ×0.4 | 🔻 개인 | -2.6억 | -2.6 | +0.0 | +0.1 | +0.0 | +2.4 | +0.1 |
| 2026-07-03 | 8,840 | 9,040 | 🔴 +3.79% | +0.28%p | ×0.6 | 🔻 개인 | -0.3억 | -0.2 | +0.0 | -0.0 | -0.0 | +0.2 | +0.1 |
| 2026-07-02 | 9,310 | 8,840 | 🔵 -5.05% | +1.39%p | ×0.5 | 🔻 개인 | -2.0억 | -2.0 | +0.0 | -0.0 | -0.0 | +2.2 | -0.2 |
| 2026-07-01 | 8,910 | 9,310 | 🔴 +4.49% | -0.22%p | ×0.7 | 🟣 투신 | +0.3억 | -0.6 | +0.0 | +0.2 | +0.9 | -1.3 | +0.7 |
| 2026-06-30 | 9,420 | 8,910 | 🔵 -5.41% | -0.31%p | ×0.4 | 🔻 개인 | -2.6억 | -2.6 | +0.0 | +0.1 | -0.0 | +2.5 | -0.1 |
| 2026-06-29 | 8,070 | 9,420 | 🔴 +16.73% | -0.62%p | ×1.5 | 🟢 외인 | +3.7억 | +5.5 | -1.8 | +0.1 | +0.0 | -3.9 | +0.0 |
| 2026-06-26 | 8,710 | 8,070 | 🔵 -7.35% | +0.11%p | ×1.0 | 🔻 개인 | -3.7억 | -3.7 | +0.0 | -0.1 | +0.0 | +3.9 | -0.1 |
| 2026-06-25 | 8,920 | 8,710 | 🔵 -2.35% | +0.12%p | ×0.7 | 🟢 외인 | +1.5억 | +1.4 | +0.0 | +0.1 | +0.1 | -1.6 | -0.0 |
| 2026-06-24 | 8,740 | 8,920 | 🔴 +2.06% | -0.23%p | ×0.6 | 🔻 개인 | -1.2억 | -1.2 | +0.0 | +0.1 | -0.0 | +1.6 | -0.5 |
| 2026-06-23 | 9,130 | 8,740 | 🔵 -4.27% | -0.66%p | ×1.0 | 🟢 외인 | +3.4억 | +3.4 | -0.1 | +0.0 | -3.2 | -0.1 | |
| 2026-06-22 | 9,540 | 9,130 | 🔵 -4.30% | -0.42%p | ×0.8 | 🔻 개인 | -1.1억 | -1.1 | +0.0 | -0.0 | +3.5 | -2.3 | |
| 2026-06-19 | 10,150 | 9,540 | 🔵 -6.01% | +0.20%p | ×0.9 | 🟢 외인 | +5.6억 | +5.6 | +0.0 | -0.1 | -5.2 | -0.4 | |
| 2026-06-18 | 10,710 | 10,150 | 🔵 -5.23% | +0.00%p | ×0.5 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | +0.2 | +0.3 | -0.2 | |
| 2026-06-17 | 10,780 | 10,710 | 🔵 -0.65% | +0.65%p | ×0.7 | 🔻 개인 | -2.5억 | -2.7 | +0.2 | +0.3 | +2.3 | -0.1 | |
| 2026-06-16 | 10,810 | 10,780 | 🔵 -0.28% | +0.83%p | ×0.4 | 🔻 개인 | -4.2억 | -4.2 | +0.0 | +0.0 | +4.2 | -0.0 | |
| 2026-06-15 | 10,320 | 10,810 | 🔴 +4.75% | +1.36%p | ×0.5 | 🔻 개인 | -4.2억 | -4.2 | +0.0 | +0.1 | +4.2 | -0.2 | |
| 2026-06-12 | 10,450 | 10,320 | 🔵 -1.24% | +1.06%p | ×0.8 | 🟢 외인 | +2.9억 | +2.9 | +0.0 | -0.0 | -2.1 | -0.8 | |
| 2026-06-11 | 9,240 | 10,450 | 🔴 +13.10% | +0.00%p | ×1.1 | 🔻 개인 | -1.7억 | -1.7 | +0.0 | +0.1 | +2.0 | -0.3 | |
| 2026-06-10 | 9,970 | 9,240 | 🔵 -7.32% | -1.50%p | ×0.8 | 🟢 외인 | +2.8억 | +2.8 | +0.0 | -0.0 | -2.9 | +0.2 | |
| 2026-06-09 | 9,890 | 9,970 | 🔴 +0.81% | +1.21%p | ×0.6 | 🟢 외인 | +4.4억 | +4.4 | +0.0 | +0.0 | -4.2 | -0.2 | |
| 2026-06-08 | 10,540 | 9,890 | 🔵 -6.17% | +0.38%p | ×0.6 | 🟢 외인 | +2.2억 | +2.2 | +0.0 | -0.1 | -2.1 | -0.1 | |
| 2026-06-05 | 11,320 | 10,540 | 🔵 -6.89% | -1.06%p | ×0.5 | 🔻 개인 | -3.0억 | -3.0 | +0.0 | +0.1 | +2.7 | +0.2 | |
| 2026-06-04 | 11,220 | 11,320 | 🔴 +0.89% | -1.61%p | ×0.6 | 🔻 개인 | -6.0억 | -6.0 | +0.0 | +0.2 | +5.2 | +0.7 | |
| 2026-06-02 | 11,590 | 11,220 | 🔵 -3.19% | -1.21%p | ×0.4 | 🟢 외인 | +5.4억 | +5.4 | +0.0 | +0.0 | -5.0 | -0.4 | |
| 2026-06-01 | 12,330 | 11,590 | 🔵 -6.00% | -0.40%p | ×0.6 | 🟢 외인 | +8.8억 | +12.2 | -3.5 | +0.0 | -6.9 | -1.9 | |
| 2026-05-29 | 13,030 | 12,330 | 🔵 -5.37% | +0.08%p | ×0.3 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | +0.1 | +0.6 | +0.2 | |
| 2026-05-28 | 13,570 | 13,030 | 🔵 -3.98% | +0.22%p | ×0.3 | 🟦 연기금 | +3.1억 | +0.5 | +2.6 | -0.2 | -3.8 | +0.9 | |
| 2026-05-27 | 13,240 | 13,570 | 🔴 +2.49% | +0.22%p | ×0.7 | 🔻 개인 | -4.5억 | -4.5 | +0.0 | +0.1 | +3.8 | +0.6 | |
| 2026-05-26 | 14,030 | 13,240 | 🔵 -5.63% | +0.64%p | ×0.5 | 🔻 개인 | -18.7억 | -18.7 | +0.0 | +0.2 | +18.4 | +0.1 | |
| 2026-05-22 | 13,000 | 14,030 | 🔴 +7.92% | +4.46%p | ×1.0 | 🟢 외인 | +17.7억 | +16.9 | +0.8 | -2.7 | -14.7 | -0.3 |
일자별 사유 (최신 위)
2026-08-04
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart -1,616억)
- 매크로 원인: 코스닥 6%대 급반등 속 경영진 자사주 매입·임상데이터·기술이전 호재로 바이오 전반 강세 (보통)
2026-07-31
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart +2,319억)
- 매크로 원인: 하반기 신약 임상·기술이전 기대감에 바이오 투자심리 회복, 개별 이슈 뒤섞인 종목별 급등 (보통)
2026-06-29
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart +305억)
- 매크로 원인: 반도체 쏠림 차익실현 후 제약·바이오로 순환매 유입 + 국민성장펀드 기대·바이오USA 훈풍에 동반 급등 (보통)
2026-06-11
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart -2,934억)
- 매크로 원인: 코스닥 바이오·소부장 쌍끌이 급등, ADC·면역항암제 신약 모멘텀 부각 (보통)